How deadly is Alzheimer?

['ⵙⵎⴷ ⵜⴰⵖⴹⴼⵜ ⴰⴷ']

ⵎⴰⴽ ⵉ ⵜⵜⴳⴳⴰ ⵍⵄⵍⵀⴰⵢⵎⴰⵔ?

ⵜⴳⴰ ⵜⵎⴰⴹⵓⵏⵜ ⵏ ⴰⵍⵣⵀⴰⵢⵎⵉⵔ ⵢⴰⵜ ⵜⵎⴰⴹⵓⵏⵜ ⵜⴰⴱⵓⵖⵍⴰⵏⵜ ⵜⴰⴱⵢⵓⵍⵓⵊⵉⵜ ⵏⵏⴰ ⵉⵙⴽⴰⵔⵏ ⴰⴷ ⵙⵙⵉⴽⴽⵙⵏⵜ ⵜⵖⵔⴰⵙⵉⵏ ⵏ ⵓⵏⵍⵍⵉ ⴰⵔ ⵜⵜⵎⵜⴰⵏⵜ, ⴰⵢⵏⵏⴰ ⴷ ⵢⵓⵡⵉⵏ ⵙ ⵜⵣⵔⵉ ⵏ ⵜⵣⵎⵎⴰⵔ ⵏ ⵓⴽⵡⵜⵜⴰⵢ ⴷ ⵓⵙⵡⵉⵏⴳⵎ ⴷ ⵓⵙⵡⵉⵏⴳⵎ.

ⵜⴳⴰ ⵜⵎⵏⵜⵉⵍⵜ ⵜⴰⵡⴰⵙⵙⵏⵜ ⵏ ⵡⴰⵍⵍⵉ ⵢⵉⵡⵉⵏ ⵙⵙⵉⵔⴰⴽⵙⵉⵡⵏ, ⵏⵏⴰ ⵉⵜⵜⵓⴳⴰⵏ 60-80% ⵏ ⵡⴰⴷⴷⴰⴷⵏ ⴰⴽⴽⵡ.

ⵜⴳⴰ ⵜⵎⴰⴹⵓⵏⵜ ⴰⴷ ⵜⴰⵎⵜⵜⴰⵏⵜ ⴳ ⵜⴳⵉⵔⴰ, ⴷ ⵓⵙⵖⵍ ⵏ ⵜⵓⴷⵔⵜ ⵏ ⵡⴰⵏⵏⴰ ⵜⵜ ⵢⵓⵊⵊⴰⵏ ⴰⴷ ⴷⵉⴷⵙ ⵉⵣⵣⵖ ⵙⴳ 4 ⴰⵔ 8 ⵏ ⵉⵙⴳⴳⵡⴰⵙⵏ, ⵎⵇⵇⴰⵔ ⵉⵖ ⵥⴹⴰⵕⵏ ⴽⵔⴰ ⵏ ⵎⴷⴷⵏ ⴰⴷ ⴷⴷⵔⵏ ⴰⵔ 20 ⵏ ⵓⵙⴳⴳⵡⴰⵙ ⵙ ⵜⵎⴰⴹⵓⵏⵜ ⴰⴷ.

ⴷⴰ ⵉⵜⵜⵎⵣⴰⵔⴰⵢ ⵓⵙⵖⵍ ⵏ ⵜⵎⵜⵜⴰⵏⵜ ⵏ ⵡⴰⵟⵟⴰⵏ ⵏ ⴰⵍⵣⵀⴰⵢⵎⵔ ⵅⴼ ⵜⵖⵓⵔⵉ ⴷ ⵉⵎⵣⴷⴰⵖⵏ ⵏⵏⴰ ⵉⵜⵜⵓⴳⴰⵏ.

ⵙ ⵎⴽ ⵏⵏⴰ ⵜⵏⵏⴰ ⵜⵎⵙⵎⵓⵏⵜ ⵏ ⴰⵍⵣⵀⴰⵢⵎⵔ, ⵜⴳⴰ ⵜⵎⴰⴹⵓⵏⵜ ⵏ ⴰⵍⵣⵀⴰⵢⵎⵔ ⵜⴰⵎⵏⵜⵉⵍⵜ ⵜⵉⵙⵙ ⵙⴰⵜ ⵏ ⵜⵎⵜⵜⴰⵏⵜ ⴳ ⵎⵉⵔⵉⴽⴰⵏ, ⴷ ⵜⴰⵎⵏⵜⵉⵍⵜ ⵜⵉⵙⵙ ⵙⵎⵎⵓⵙⵜ ⵏ ⵜⵎⵜⵜⴰⵏⵜ ⴳ ⵡⵉⵍⵍⵉ ⵢⵓⵡⵜⵏ 65 ⵏ ⵓⵙⴳⴳⵡⴰⵙ ⵏⵖ ⵓⴳⴳⴰⵔ.

ⴳ ⵓⵙⴳⴳⵡⴰⵙ ⵏ 2019, ⵉⵜⵜⵓⵣⵎⵎⴻⵎ ⵎⴰⵙ ⵜⴳⴰ ⵜⵎⴰⴹⵓⵏⵜ ⵏ ⴰⵍⵣⵀⴰⵢⵎⵔ ⵜⴰⵎⵏⵜⵉⵍⵜ ⵜⴰⴷⵙⵍⴰⵏⵜ ⵏ ⵜⵎⵜⵜⴰⵏⵜ ⵏ 121.9444 ⵓⴼⴳⴰⵏ ⴳ ⵎⵉⵔⵉⴽⴰⵏ.

ⵉⵇⵇⴰⵏⴷ ⴰⴷ ⵏⵙⵙⴽⵜⵉ ⵎⴰⵙ ⵓⵙⵖⵍ ⵏ ⵜⵎⵜⵜⴰⵏⵜ ⵏ ⵡⴰⵟⵟⴰⵏ ⵏ ⴰⵍⵣⵀⴰⵢⵎⵔ ⵓⵔ ⵉⴷⴷ ⵖⴰⵙ ⵙ ⵡⴰⵟⵟⴰⵏ ⵙ ⵉⵅⴼ ⵏⵏⵙ, ⵎⴰⵛⴰ ⴷⴰ ⵉⴷⴷⵉ ⴰⵡⴷ ⵙ ⵉⵎⵓⴽⵔⵉⵙⵏ ⴷ ⵜⵎⵙⴰⵔⵉⵏ ⵏ ⵜⴷⵓⵙⵉ ⵢⴰⴹⵏⵉⵏ ⵏⵏⴰ ⴷ ⵉⵜⵜⵉⵍⵉⵏ ⵙ ⵜⵢⴰⴼⵓⵜ ⵏ ⵡⴰⵟⵟⴰⵏ.

ⵎⴽ ⵍⵍⵉ ⵉⵜⵜⴱⵓⵖⵍⵓ ⵡⴰⴷⴷⴰⴷ ⵏ ⵜⵎⴰⴹⵓⵏⵜ, ⵉⵖⵢ ⴰⴷ ⵢⵉⵍⵉ ⵉ ⵉⵏⵎⵓⵔⴰⵏ ⴰⴷⴷⴰⴷ ⵉⵛⵇⵇⴰⵏ ⴳ ⵉⵎⵓⵙⵙⵓⵜⵏ ⵏ ⵜⵓⴷⵔⵜ ⵏ ⴽⵓ ⴰⵙⵙ, ⵣⵓⵏⴷ ⵜⵉⵖⵔⵉ, ⴰⵙⵏⵓⵃⵢⵓ, ⴷ ⵓⵙⵏⴼⵍ, ⵏⵏⴰ ⵉⵖⵢ ⴰⴷ ⵢⴰⵡⵉ ⵖⵔ ⵜⵣⴷⴰⵢⵜ, ⵜⵉⵎⵇⵇⴰ, ⴷ ⵉⵎⵓⴽⵔⵉⵙⵏ ⵏ ⵜⴷⵓⵙⵉ ⵢⴰⴹⵏ.

ⵙ ⵓⵙⵎⵔⵙ ⵏ ⵓⵢⴰ, ⵥⴹⴰⵕⵏ ⵉⵡⴷⴰⵏⵏ ⵍⵍⵉ ⴷⴰⵔ ⵜⵍⵍⴰ ⵜⵎⴰⴹⵓⵏⵜ ⵏ ⴰⵍⵣⵀⴰⵢⵎⵔ ⴰⴷ ⵍⴽⵎⵏ ⵙ ⵢⴰⵏ ⵓⵙⵓⵔⵙ ⴰⵎⵔⵏⵉⵡ ⵏ ⵜⵉⵕⵥⵉⵏ, ⴷ ⵓⵏⵉⵎⵓⵏⵢⴰ, ⴷ ⵡⴰⵟⵟⴰⵏⵏ ⵢⴰⴹⵏⵉⵏ.

ⵎⵇⵇⴰⵔ ⵓⵔ ⵉⵍⵍⵉ ⴽⵔⴰ ⵏ ⵓⵙⴰⴼⴰⵔ ⵉ ⵡⴰⵟⵟⴰⵏ ⵏ ⴰⵍⵣⵀⴰⵢⵎⵔ, ⵍⵍⴰⵏⵜ ⵜⵣⵎⵎⴰⵔ ⵏⵏⴰ ⵉⵖⵉⵏ ⴰⴷ ⴰⵡⵙⵏ ⴳ ⵓⵙⵎⵀⵍ ⵏ ⵜⵎⴰⵜⴰⵔⵉⵏ ⴷ ⵓⵙⵖⵓⴷⵓ ⵏ ⵓⵙⵖⵓⴷⵓ ⵏ ⵜⵓⴷⵔⵜ.

ⴰⵔ ⵜⵜⵓⴳⴰⵏⵜ ⵜⵣⵔⴰⵡⵉⵏ ⴰⴼⴰⴷ ⴰⴷ ⵜⵜⵓⵙⴱⵓⵖⵍⵓⵏ ⵜⵊⵉⵊⵊⵉⵜⵉⵏ ⵜⵉⵎⴰⵢⵏⵓⵜⵉⵏ ⴷ ⴰⴷ ⵜⴰⴼⴼⵖ ⴳ ⵜⴳⵉⵔⴰ ⴰⵙⴰⴼⴰⵔ ⵉ ⵜⵎⴰⴹⵓⵏⵜ ⴰⴷ ⵉⵛⵇⵇⴰⵏ.

['ⵉⵙⵓⴳⴰⵎ']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Zhu B, Chen X, Li W, Zhou D: Effect of Alzheimer Disease on Prognosis of Intensive Care Unit (ICU) Patients: A Propensity Score Matching Analysis. Med Sci Monit. 2022, 28 (): e935397.

Almeida MC, Gomes Cde M, Nascimento LF: Spatial distribution of deaths due to Alzheimer's disease in the state of São Paulo, Brazil. Sao Paulo Med J. 2014, 132 (4): 199-204.

Aevarsson O, Svanborg A, Skoog I: Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia. Arch Neurol. 1998, 55 (9): 1226-32.

Mortality from Alzheimer disease--United States, 1979-1987. MMWR Morb Mortal Wkly Rep. 1990, 39 (43): 785-8.

Breitner JC: Clinical genetics and genetic counseling in Alzheimer disease. Ann Intern Med. 1991, 115 (8): 601-6.

Iulita MF, Garzón Chavez D, Klitgaard Christensen M, Valle Tamayo N, Plana-Ripoll O, Rasmussen SA, Roqué Figuls M, Alcolea D, Videla L, Barroeta I, Benejam B, Altuna M, Padilla C, Pegueroles J, Fernandez S, Belbin O, Carmona-Iragui M, Blesa R, Lleó A, Bejanin A, Fortea J: Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome. JAMA Netw Open. 2022, 5 (5): e2212910.

['ⴰⵙⴱⴷⵉⴷ: ⴰⵎⵙⵏⵉⵊⵊⵉ']

['ⴰⵙⵉⵜ ⴰⴷ, ⴷⴰ ⵉⵜⵜⵓⴼⴽⴰ ⵖⴰⵙ ⵉ ⵜⵖⴰⵡⵙⵉⵡⵉⵏ ⵏ ⵓⵙⴳⵎⵉ ⴷ ⵉⵏⵖⵎⵉⵙⵏ, ⵓⵔ ⵉⴳⵉ ⴰⵖⴰⵡⴰⵙ ⵏ ⵜⵉⴽⴽⵉ ⵏ ⵜⵉⵏⵓⵔⵣⵉⵜⵉⵏ ⵜⵉⴷⵓⵙⴰⵏⵉⵏ ⵏⵖⴷ ⵜⵉⵡⵓⵔⵉⵡⵉⵏ ⵜⵉⵣⵣⵓⵍⴰⵏⵉⵏ.']

['ⵓⵔ ⵉⵅⵚⵚⴰ ⴰⴷ ⵜⵜⵓⵙⵎⵔⵙ ⵉⵏⵖⵎⵉⵙⵏ ⵉⵜⵜⵓⴼⴽⴰⵏ ⴳ ⵓⵙⵎⵔⵙ ⵏ ⵓⵙⵎⵉⴳⵍ ⵏⵉⵖ ⵉⵊⵉⵊⵊⵉ ⵏ ⵉⵎⵓⴽⵔⵉⵙⵏ ⵏ ⵜⴷⵓⵙⵉ ⵏⵖⴷ ⵜⵎⴰⴹⵓⵏⵉⵏ, ⴷ ⵡⵉⵏⵏⴰ ⵉⵔⴰⵏ ⴰⵙⵖⵏⵓ ⴰⵎⵙⵏⵉⵊⵊⵉ ⴰⵡⵏ ⵉⵜⵜⵓⴼⴽⴰⵏ ⵉⵇⵇⴰⵏ ⴰⴷ ⵉⵙⴰⵡⵍ ⴷ ⵢⴰⵏ ⵓⵎⵙⵏⵉⵊⵊⵉ ⵉⵜⵜⵓⵊⵊⴰⵏ.']

['ⵙⵙⴽⵜⵉ ⴳ ⵜⴱⵔⴰⵜ ⵎⴰⵙ ⵜⵣⵟⵟⴰ ⵏ ⵜⵎⴰⵖⵓⵏⵜ ⵏⵏⴰ ⵉⵜⵜⴰⵔⴰⵏ ⵜⵉⵎⵔⴰⵔⵓⵜⵉⵏ ⵉ ⵉⵙⵇⵙⵉⵜⵏ, ⵓⵔ ⵜⴽⴽⵉ ⵜⵖⴰⵔⴰ ⴽⵉⴳⴰⵏ ⴳ ⵎⴰⴷ ⵉⵥⵍⵉⵏ ⵙ ⵜⵓⵎⴰⵢⵜ ⵏ ⵓⵟⵟⵓⵏ. ⵙ ⵓⵎⴷⵢⴰ, ⵓⵟⵟⵓⵏ ⵏ ⵎⴷⴷⵏ ⵉⵜⵜⵓⵙⵏⴼⴰⵍⵏ ⵉ ⵜⵎⴰⴹⵓⵏⵜ ⵉⵥⵍⵉⵏ.']

['ⴰⵀⴰ ⵣⵣⵔⵉⵢ ⵉ ⵓⵎⵙⴰⵙⴰ ⵏ ⵓⴷⵓⴽⵜⵓⵕ ⵏⵏⴽ ⵏⵖⴷ ⴽⵔⴰ ⵏ ⵓⵎⵙⵙⵉⵡⵍ ⵏ ⵜⴷⵓⵙⵉ ⵢⴰⴹⵏ ⵉⵖⵉⵢⵏ ⴳ ⵎⴰⴷ ⵉⵥⵍⵉⵏ ⵙ ⵓⴷⴷⴰⴷ ⵏ ⵜⴷⵓⵙⵉ ⵏⵏⴽ. ⵓⵔ ⴰⴽⴽⵡ ⵜⵃⵍⴰⵎ ⴰⵖ ⴰⵖⴰⵎⵓⵙ ⵏ ⵓⴷⵓⵙⵉ ⵏⵖⴷ ⵜⵉⵖⵣⵉ ⴳ ⵓⵙⵣⵣⵔⵉⵢ ⵏⵏⵙ ⴰⵛⴽⵓ ⵏⵜⵜⴰⵜ ⵜⵖⵔⵉⴷ ⴳ ⵓⵙⵉⵜ ⴰⴷ. ⵎⴽ ⵜⵓⵔⴷⴰ ⵎⴰⵙ ⴷⴰⵔⴽ ⴰⴷ ⵢⵉⵍⵉ ⵢⴰⵏ ⵓⴷⴷⴰⴷ ⵏ ⵜⴷⵓⵙⵉ ⵉⵣⵉⵍⵏ, ⵙⴰⵡⵍⴰⵜ ⵙ 911 ⵏⵖⴷ ⴷⴷⵓ ⵙ ⵓⵙⵉⵔⴰ ⵏ ⵓⵣⵣⵔⴰⵢ ⵏ ⵣⵉⴽⴽ. ⵓⵔ ⴷⴰ ⵉⵜⵜⵓⵙⴽⴰⵔ ⴽⵔⴰ ⵏ ⵓⵣⴷⴰⵢ ⵏ ⵓⵎⵙⴳⵏⴰⴼ ⴷ ⵓⵎⵏⵉⴳ ⵙ ⵓⵙⵉⵜ ⴰⴷ ⵏⵖⴷ ⴰⵙⵎⵔⵙ ⵏⵏⵙ. ⵓⵔ ⴷⴰ ⵜⵙⴽⴰⵔ ⴱⵢⵓⵎⵉⴷⵍⴱ ⵏⵖⴷ ⵉⵎⵙⵡⵓⵔⵉⵏ ⵏⵏⵙ ⵏⵖⴷ ⴽⵔⴰ ⵏ ⵓⵎⴷⵔⴰⵡ ⴳ ⵓⵙⵉⵜ ⴰⴷ ⴽⵔⴰ ⵏ ⵓⵙⵎⵏⵉⴷ, ⵙ ⵡⴰⵡⴰⵍ ⵏⵖⴷ ⵙ ⵓⵙⵓⵎⵔ, ⴳ ⵎⴰⴷ ⵉⵥⵍⵉⵏ ⵙ ⵉⵏⵖⵎⵉⵙⵏ ⵉⵜⵜⵓⴼⴽⴰⵏ ⴳ ⵓⵙⵉⵜ ⴰⴷ ⵏⵖⴷ ⵓⵙⵎⵔⵙ ⵏⵏⵙ.']

['ⵉⵣⵍⵉ: ⵉⵣⵔⴼⴰⵏ ⵏ ⵜⵉⵔⵔⴰ']

['ⵉⵍⵍⴰ ⴳ ⵓⵙⵍⴳⵏ ⵏ ⵓⵣⵔⴼ ⴰⵎⵓⵟⵟⵓⵏ ⵏ ⵓⵙⵏⴼⵍ ⵏ ⵜⵏⵖⵎⴰⵙⵜ ⵏ ⵓⵙⴳⴳⵡⴰⵙ ⵏ 1998, 17 U.S.C. § 512 (DMCA) ⵜⴰⵙⵏⵜⴰⵢⵜ ⵉ ⵉⵎⵥⵢⴰⵏⵏ ⵏ ⵉⵣⵔⴼⴰⵏ ⵏ ⵜⵏⵖⵎⴰⵙⵜ ⵏⵏⴰ ⵙⵙⵉⵜⵉⵎⵏ ⵉⵙ ⵉⵏⵖⵎⵉⵙⵏ ⵏⵏⴰ ⴷ ⵉⵜⵜⴼⴼⵖⵏ ⴳ ⵡⴰⵏⵜⵉⵔⵏⵉⵜ ⴷⴰ ⵜⵜⴳⴳⴰⵏ ⵉⵣⵔⴼⴰⵏ ⵏⵏⵙⵏ ⴷⴷⴰⵡ ⵓⵣⵔⴼ ⴰⵎⵓⵟⵟⵓⵏ ⴰⵎⵉⵔⵉⴽⴰⵏⵉ. ']

['ⵎⴽ ⵜⵍⵍⵉⴷ ⵙ ⵜⵖⴰⵍⵜ ⵉⵖⵓⴷⴰⵏ ⵎⴰⵙⴷ ⴽⵔⴰ ⵏ ⵜⵓⵎⴰⵢⵜ ⵏⵖⴷ ⴽⵔⴰ ⵏ ⵓⵙⵏⴼⴰⵔ ⵉⵜⵜⵓⴼⴽⴰⵏ ⴳ ⵓⵙⴷⴰⵡ ⵏⵏⵓⵏ ⵏⵖⴷ ⵜⵉⵙⵏⵙⵉ ⵏⵏⵓⵏ ⴷⴰ ⵉⵙⵙⴽⴰⵔ ⵜⵉⵕⵥⵉ ⵏ ⵓⵣⵔⴼ ⵏⵏⵓⵏ ⵏ ⵜⵉⵔⵔⴰ, ⵉⵖⵢ ⴰⴷ ⵜⴰⴷ ⴼⵍⵍⴰⵙ ⵏⵙⵔⵖⴷ (ⵏⵖⴷ ⴰⵎⴷⵢⴰⵣ ⵏⵏⴽ) ⵢⴰⵏ ⵓⵙⵏⵖⵎⵙ ⵏ ⵓⵙⵓⵜⵔ ⵏ ⵓⵙⵏⴼⴰⵔ ⵏ ⵜⵓⵎⴰⵢⵜ ⵏⵖⴷ ⴰⵙⵏⴼⴰⵔ ⴰⴷ ⵏⵖⴷ ⴰⵙⴱⴷⴷⵉ ⵏ ⵓⵣⵔⴼ ⵏ ⵓⴽⵛⵛⵓⵎ ⵖⵔⵙⵏ. ']

['ⵉⵇⵇⴰⵏ ⴰⴷ ⵜⵜⵢⵓⵔⴰⵢ ⵜⴱⵔⴰⵜ ⴰⴷ ⵙ ⵜⵖⴰⵔⴰⵙⵜ ⵏ ⵜⵉⵔⵔⴰ ⵙ ⵜⴱⵔⴰⵜ ⵜⵉⵍⵉⴽⵜⵕⵓⵏⵉⵜ (ⵥⵕ ⴰⵙⴷⴰⵡ ⵏ ⵜⴱⵔⴰⵜ ⵜⵉⵍⵉⴽⵜⵕⵓⵏⵉⵜ ⴳ ⵓⵎⵏⵏⵉ "ⵉⵎⵢⴰⵡⴰⴹⵏ").']

['ⴷⴰ ⵉⵜⵜⴻⵖⵜⴰⵙ ⵓⵙⵍⴳⵏ ⵏ ⵓⵎⵏⵖⵉ ⵅⴼ ⵉⵣⵔⴼⴰⵏ ⵏ ⵓⵎⴳⴰⵢ ⵉⵙ ⴷ ⵉⵇⵇⴰⵏ ⴰⴷ ⴳⵉⵙ ⵉⵍⵉⵏ ⵉⵏⵖⵎⵉⵙⵏ ⴰⴷ: (1) ⴰⵙⵏⵓⵎⵍ ⵏ ⵜⵡⵓⵔⵉ ⵉⵍⴰⵏ ⵉⵣⵔⴼⴰⵏ ⵏ ⵓⵎⴳⴰⵢ ⵏⵏⴰ ⵉⴳⴰⵏ ⴰⵙⵏⵜⵍ ⵏ ⵓⵣⵔⴼ ⵏ ⵓⵎⴳⴰⵢ; (2) ⴰⵙⵏⵓⵎⵍ ⵏ ⵜⵓⵎⴰⵢⵜ ⵏⵏⴰ ⵉⴳⴰⵏ ⴰⵙⵏⵓⵎⵍ ⵏ ⵉⵣⵔⴼⴰⵏ ⴷ ⵉⵏⵖⵎⵉⵙⵏ ⵏⵏⴰ ⵢⵓⵙⴰⵏ ⵃⵎⴰ ⴰⴷ ⵜ ⵏⴰⴼ; (3) ⵉⵏⵖⵎⵉⵙⵏ ⵏ ⵓⵎⵢⴰⵡⴰⴹ ⴰⴽⴷⴽ, ⴳ ⵉⵍⵍⴰ ⵓⵙⵖⵉⵎ ⵏⵏⴽ ⴷ ⵓⵟⵟⵓⵏ ⵏ ⵜⵉⵍⵉⴼⵓⵏ ⴷ ⵓⴷⵖⴰⵔ ⵏ ⵍⵢⵉⴱⵍ; (4) ⴰⵙⵉⵡⴹ ⵏⵏⴽ ⵏ ⵓⵙⵏⵓⵎⵍ ⵉⵖⵓⴷⴰⵏ ⵏⵏⴰ ⴳ ⵜⵍⵍⴰ ⵜⵣⵎⵎⴰⵔ ⵏ ⵓⵙⵏⵓⵎⵍ ⵏ ⵓⵙⵏⴼⵍ ⵏⵏⴰ ⵙ ⵉⵜⵜⵓⵙⵎⴳⴰⵍ ⵓⵔ ⵜ ⵢⵓⵊⵊⵉ ⵓⵎⵏⴳⴰⵢ ⵏ ⵉⵣⵔⴼⴰⵏ ⵏ ⵓⵎⴳⴰⵢ, ⵏⵖⴷ ⵓⵎⴷⵢⴰⵣ ⵏⵏⵙ, ⵏⵖⴷ ⵙ ⵓⴹⴼⴰⵕ ⵏ ⴽⵔⴰ ⵏ ⵓⵙⵍⴳⵏ; ']

['5. ⵢⴰⵏ ⵓⵙⵉⵡⴹ ⵏⵏⴽ, ⵉⵜⵜⵓⵙⴳⵎⴰⴹⵏ ⴷⴷⵓ ⵏ ⵓⵃⵟⵟⵓ ⵏ ⵜⵔⴳⴰⵍⵜ, ⵎⴰⵙ ⵉⵏⵖⵎⵉⵙⵏ ⵉⵍⵍⴰⵏ ⴳ ⵓⵏⵖⵎⵉⵙ ⴰⴷ ⴳⴰⵏ ⵉⵙⴷⴰⵡⵏ ⴷ ⵎⴰⵙ ⵖⵓⵔⴽ ⵜⵓⵔⴰⴳⵜ ⴰⴼⴰⴷ ⴰⴷ ⵜⵙⵎⴷⵔⴼ ⵜⵉⵡⵏⴳⵉⵎⵉⵏ ⵉⵜⵜⵉⵏⵉ ⵉⵙ ⵜⵜⵓⵙⵏⴼⴰⵍⵏ;']

['ⴷ (6) ⵢⴰⵏ ⵓⵣⵎⵎⴻⵎ ⴰⴽⵎⴰⵎ ⵏⵖⴷ ⴰⵍⵉⴽⵜⵔⵓⵏⵉ ⵏ ⵉⵎⵥⵍⵉ ⵏ ⵓⵣⵔⴼ ⵏ ⵜⵉⵔⵔⴰ ⵏⵖⴷ ⵢⴰⵏ ⵓⴼⴳⴰⵏ ⵉⵜⵜⵓⵙⵎⴰⴳⵍⵏ ⵙ ⵜⵡⵓⵔⵉ ⴳ ⵜⵙⴳⴰ ⵏ ⵉⵎⵥⵍⵉ ⵏ ⵓⵣⵔⴼ ⵏ ⵜⵉⵔⵔⴰ. ']

['ⵎⴽ ⵓⵔ ⵜⵙⵎⵓⵜⵜⵉⴷ ⴽⵓⵍⵍⵓ ⵉⵏⵖⵎⵉⵙⵏ ⴰⴼⵍⵍⴰ, ⵉⵥⴹⴰⵕ ⴰⴷ ⵉⵙⵙⵉⵍⵉ ⵓⵙⵙⵉⵖⵣⵉⵏ ⵏ ⵓⵙⵎⴽⵍ ⵏ ⵡⴰⵙⵉⴼ ⵏⵏⴽ.']

['ⴰⵎⵢⴰⵡⴰⴹ']

['ⵙⵇⵙⴰⵖ ⴷⵉⵖ ⴰⴷ ⵜⵙⵏⵖⵎⵙⴷ ⴽⵔⴰ ⵏ ⵓⵙⵇⵙⵉ/ ⵜⴰⵏⵏⴰⵢⵜ.']

How deadly is alzheimer?

Alzheimer's disease is a progressive neurological disorder that causes brain cells to degenerate and die, leading to a decline in memory, thinking, and reasoning skills.

It is the most common cause of dementia, accounting for 60-80% of all cases.

The disease is ultimately fatal, with the average life expectancy after diagnosis being 4-8 years, although some people can live up to 20 years with the disease.

The mortality rate for Alzheimer's disease varies depending on the study and the population being examined.

According to the Alzheimer's Association, Alzheimer's disease is the sixth leading cause of death in the United States, and it is the fifth leading cause of death for those aged 65 and older.

In 2019, Alzheimer's disease was reported as the underlying cause of death for 121,9444 people in the United States.

It is important to note that the mortality rate for Alzheimer's disease is not solely due to the disease itself, but also due to complications and other health issues that arise as a result of the disease.

As the disease progresses, individuals may experience difficulty with activities of daily living, such as eating, bathing, and dressing, which can lead to malnutrition, infections, and other health problems.

Additionally, individuals with Alzheimer's disease may be at an increased risk of falls, pneumonia, and other infections.

While there is currently no cure for Alzheimer's disease, there are treatments available that can help manage symptoms and improve quality of life.

Research is ongoing to develop new treatments and ultimately find a cure for this devastating disease.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.

['ⵖⴼ']

['ⴷⴰ ⵉⵙⵙⵎⵔⴰⵙ ⴱⵢⵓⵎⵉⴷⵍⴱ ⵉⵎⴰⵙⵙⵏ ⵏ ⵓⵙⵖⵉⵡⵙ ⵉⵙⵎⵎⴰⵏⵏ (ⴰⵍⴳⵓⵔⵉⵜⵎ ⵏ ⵓⵍⵎⵎⵓⴷ ⵏ ⵉⵎⵉⵙⵏ) ⵉ ⵓⵙⵓⴼⵖ ⵏ ⵉⴽⵔⵡⴰⵏ ⵏ ⵉⵙⵇⵙⵉⵜⵏ ⴷ ⵜⵎⵔⴰⵔⵓⵜⵉⵏ.']

['ⴷⴰ ⵏⵙⵙⵏⵜⵉ ⵙ 35 ⵎⵍⵢⵓⵏ ⵏ ⵜⵥⵕⵉⴳⵉⵏ ⵜⵉⵎⵙⵏⵉⵊⵊⵉⵏ ⵏ ⵜⵓⴷⵔⵜ ⵏ ⴱⵓⴱⵎⵉⴷ/ⵎⵉⴷⵍⵉⵏ. ⴰⵡⴷ ⵜⵉⴼⵔⵜ ⵏ ⵡⵉⴱ ⵏ ⵔⵉⴼⵉⵏⴷⵡⵉⴱ.']

['ⵥⵕ "ⵜⵓⵎⴰⵔ" ⴰⵡⴷ "ⴰⵙⵎⵉⴳⵍ".']